Rose bengal sodium clinical trials
Also written PV-10 and Rose Bengal Disodium.
A product of Rose Bengal; its studies count on that page too.
How each study uses rose bengal sodium is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2015 (2)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2015 | 2 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 0
Provectus Biopharmaceuticals, Inc. (4) · Provectus Pharmaceuticals (2)
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Rose Bengal
Studies
Open first, then newest update. How each study uses rose bengal sodium is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- PV-10 in Combination With Pembrolizumab for Treatment of Metastatic MelanomaActive, not recruitingPhase 1/2Provectus Biopharmaceuticals, Inc.NCT02557321Written as PV-10
- A Phase 1 Study of PV-10 Chemoablation of Neuroendocrine Tumours (NET) Metastatic to the LiverStatus unknownPhase 1Provectus Biopharmaceuticals, Inc.NCT02693067Written as Rose bengal disodium
- A Study to Assess PV-10 Chemoablation of Cancer of the LiverStatus unknownPhase 1Provectus Biopharmaceuticals, Inc.NCT00986661Written as PV-10 (10% rose bengal disodium)
- PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous MelanomaTerminatedPhase 3Provectus Biopharmaceuticals, Inc.NCT02288897Written as PV-10 (10% rose bengal disodium)
- Phase 2 Study of Intralesional PV-10 for Metastatic MelanomaCompletedPhase 2Provectus PharmaceuticalsNCT00521053Written as PV-10 (10% rose bengal disodium)
- Intralesional PV-10 Chemoablation of Metastatic MelanomaCompletedPhase 1Provectus PharmaceuticalsNCT00219843Written as PV-10 (rose bengal disodium, 10%)
Codes
What other systems call rose bengal sodium · ClinicalTrials.gg INT015793
- UNII (FDA) 956575SN5LROSE BENGAL SODIUMOne source FDA
- RxNorm 1362690One source FDA
- NCI Thesaurus C87723Rose Bengal SodiumOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 956575SN5L | ROSE BENGAL SODIUM | One source FDA |
| RxNorm | 1362690 | — | One source FDA |
| NCI Thesaurus | C87723 | Rose Bengal Sodium | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.